スポンサーリンク
特定非営利活動法人 バイオ＆ソーシャル・サイエンス推進国際研究交流会 | 論文
- Newborn screening and related policy against Phenylketonuria in China
- Current situation and prospects of newborn screening and treatment for Phenylketonuria in China ‒ compared with the current situation in the United States, UK and Japan
- A high-salinity solution with calcium chloride enables RNase-free, easy plasmid isolation within 55 minutes
- Study and analysis of the state of rare disease research in Shandong Province, China
- Unusual causes of upper gastrointestinal bleeding: Review of Chinese literature
- Design, synthesis and biological evaluation of naphthalimidebased fluorescent probes for α1-adrenergic receptors
- Leiomyosarcoma: Principles of management
- Clinicopathological subclassification of biliary cystic tumors: Report of 4 cases with a review of the literature
- A case of psoriasis accompanied by arthritis after delivery
- Prediction of response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer
- Identification of a germline mutation in the HRPT2 gene in a Chinese family with parathyroid carcinomas
- Chronic intestinal pseudo-obstruction due to lymphocytic intestinal leiomyositis: Case report and literature review
- Oxoprothracarcin, a novel pyrrolo[1,4]benzodiazepine antibiotic from marine Streptomyces sp. M10946
- A lesson from Japan: Research and development efficiency is a key element of pharmaceutical industry consolidation process
- Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver
- The current status of orphan drug development in Europe and the US
- Pelizaeus-Merzbacher disease: Molecular diagnosis and therapy
- A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: Safety report of the UFT/LV study
- Prader-willi syndrome: A case report and a Chinese literature review
- High prevalence of HIV-associated neurocognitive disorder in HIV-infected patients with a baseline CD4 count ≤ 350 cells/μL in Shanghai, China